Compositions with reduced hepatotoxicity
Pharmaceutical compositions of hepatotoxic compounds are provided in which the hepatotoxicity of the compounds is mitigated by including quantities of nicotinamide and methionine in the composition. Folic acid also can be included to further mitigate the hepatotoxic effects. The hepatotoxic compounds can include acetaminophen, methotrexate, atorvastatin, simvastatin, niacin, flucanozole, divalproex sodium, and valproic acid.
1. A method of mitigating the hepatotoxicity of a hepatotoxic compound, the method comprising:
formulating a composition of the hepatotoxic compound by combining a quantity of the hepatotoxic compound with a quantity of nicotinamide, a quantity of methionine, and a quantity of folic acid into a single individual dosage form selected from the group consisting of a capsule, a tablet or an oral solution,
and further administering the individual dosage form containing the hepatotoxic compound, nicotinamide, folic acid, and methionine to a patient in need of the hepatotoxic compound,
wherein the hepatotoxic compound is selected from the group consisting of acetaminophen, atorvastatin, simvastatin, niacin, fluconazole, divalproex sodium, and valproic acid.
2. The method of claim 1 wherein said composition is formulated such that for each dose of the hepatotoxic compound in the composition, the nicotinamide is present in the amount of 5-500 mg, and the methionine is present in the amount of 25-500 mg.
3. The method of claim 2 wherein said nicotinamide is present in the amount of 25-200 mg per dose of the hepatotoxic compound.
4. The method of claim 2 wherein said methionine is present in the amount of 10-100 mg per dose of the hepatotoxic compound.
5. The method of claim 1 wherein said folic acid is present in the amount of 50 mcg-5 mg per dose of the hepatotoxic compound.
6. The method of claim 5 wherein said folic acid is present in the amount of 500 mcg-1 mg per dose of the hepatotoxic compound.
7. The method of claim 1 , wherein said acetaminophen is present in the amount of 80 mg-1000 mg per dose.